Month: April 2022

Sach Sankpal Acuity Brands Appoints Sach Sankpal, pictured here, as Senior Vice President, Growth and TransformationAtlanta, April 07, 2022 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (“Acuity” or the “Company”), a market-leading industrial technology company, today announced the appointment of Sach Sankpal as Senior Vice President, Growth and Transformation, and a member of the executive leadership team. Sankpal will lead the technology organization, deploy the Company’s Better.Smarter.Faster. operating system, and direct integration efforts for future Acuity mergers and acquisitions. He brings extensive experience leading successful business transformations in the industrial sector.   “We are excited to have Sach on our team,” said Neil Ashe, Chairman, President and CEO, Acuity Brands,...

HOLLYWOOD, Fla., April 07, 2022 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of compliance, technology, engineering, and environmental consulting solutions, announced today that it will host an Investor Day on Thursday, May 26, 2022 at 10:00 am Central Time. The Investor Day will be held at The Glen Club in Glenview, IL during the first round of the NV5 Invitational, an annual event on the PGA TOUR’s Korn Ferry Tour schedule. The 2022 Investor Day will present NV5’s strategic plan to continue driving growth and margins that exceed the industry average. NV5 Chairman and CEO, Dickerson Wright, and Chief Financial Officer, Edward Codispoti, will host the event followed by a question and answer session.   Investor Day will conclude with demonstrations of the technologies that are expected...

LAKE FOREST, Ill., April 07, 2022 (GLOBE NEWSWIRE) — Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its first quarter 2022 earnings release and teleconference call.Earnings release:   Wednesday, May 4, 2022, after market close     Webcast and Teleconference:   Thursday, May 5, 2022 at 8:00 a.m. ET.     Pactiv Evergreen Participants:   Michael King, CEO    Michael Ragen, CFO    Dhaval Patel, SVP, Investor Relations & StrategyParticipants may access the live webcast on the Company’s Investor Relations website at https://investors.pactivevergreen.com/news-events/events-presentations. The call may also be accessed by dialing 1-844-825-9789 from the U.S. or 1-412-317-5180 internationally and using access code 10165348. About Pactiv Evergreen Inc. Pactiv Evergreen Inc. is one of...

Veteran executive, Stanford lecturer and public company board member brings decades of relevant international corporate experience to Arteris IPClaudia Fan Munce New Arteris IP Board MemberCAMPBELL, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Arteris IP (NASDAQ: AIP), a leading provider of system IP consisting of network-on-chip (NoC) interconnect and IP deployment software that accelerate system-on-chip (SoC) creation, today announced that Claudia Fan Munce will join Arteris IP’s Board of Directors and will commence her service at the company’s May 2022 board and committee meetings.   Claudia Fan Munce’s distinguished 30-year career at IBM culminated with her role as Vice President of Corporate Development. Throughout her tenure at IBM, she held various positions, including executive roles in engineering, IP licensing, and IBM...

CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced the details of its webcast to discuss updated clinical data from the ongoing monotherapy Phase 1 arm of the Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors and relapsed/refractory acute myeloid leukemia on April 8, 2022, at 1:15 p.m. ET. In addition to members of the Rubius management team, Alexander I. Spira, M.D., Ph.D., FACP​, Co-Director, Virginia Cancer Specialists Research Institute, Director, Thoracic and Phase 1 Program and RTX-240 clinical investigator, will join...

Positioned as a Magic Quadrant Leader for the fourth consecutive year, Manhattan Associates offers the only cloud-native, 100 percent microservices TMS ATLANTA, April 07, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions, today announced that, for the fourth year in a row, it has been named a Leader in Gartner Inc. Magic Quadrant™ for Transportation Management Systems.1 Today’s logistics networks are incredibly complex and transportation management systems are under tremendous pressure to perform more shipments with fewer resources. Manhattan Active® Transportation Management was redesigned and rebuilt last year with the industry’s fastest and smartest shipping optimization engine to create the industry’s most technologically advanced transportation planning and...

NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the 21st Annual Needham Virtual Healthcare Conference on April 11th-14th, 2022. The company will present an overview on Wednesday, April 13th, 2021 at 3:00 pm ET. Management will also be available for one-on-one meetings. Investors may view the presentation and register for a one-on-one meeting by emailing conferences@needhamco.com. About LifeMDLifeMD™ is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical...

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity Horizons in Oncology Conference on Thursday, April 14, 2022 at 12:00 p.m. Eastern. The webcast presentation can be accessed from the investors section of the Neoleukin website at http://investor.neoleukin.com/events. An archived replay will also be available on the company website for at least 30 days following the event. About Neoleukin Therapeutics, Inc. Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein...

CHICAGO, April 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Epazz, Inc. (OTCPINK: EPAZ), a leading provider of cloud-based business software solutions, announced today that it reported revenues of $1.9 million for 2021 compared to $1.4 million for 2020. It also reported a positive EBITDA of $102,000, compared to an EBITDA of $8,083 for 2021, an increase of 1,168%. The DeskFlex desk booking software, which will be launching its Metaverse Virtual Office later this year, fueled the increase in revenue. The company started making operational improvements in 2020, and the results started to appear in 2021. The company has been consolidating the services and operations of its subsidiaries for its Chicago operations, resulting in cost savings. The company is also reinvesting its savings back into product development, including for its...